A drug with the SMILES Cc1ccn2cc(C(=O)N3CCN(c4cnn(-c5ccccc5)c(=O)c4Cl)CC3)nc2c1 has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM of -46.660%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1ccn2cc(C(=O)N3CCN(c4cnn(-c5ccccc5)c(=O)c4Cl)CC3)nc2c1
Cc1ccn2cc(C(=O)N3CCN(c4cnn(-c5ccccc5)c(=O)c4Cl)CC3)nc2c1
4-chloro-5-[4-(7-methylimidazo[1,2-a]pyridine-2-carbonyl)piperazin-1-yl]-2-phenylpyridazin-3-one